In response to demand growth, Rayner has completed an extensive expansion of its Worthing (UK) production facility, doubling the number of intraocular lenses (IOLs)

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for SYD-101 – a proprietary low-dose

Three outstanding Aboriginal and Torres Strait Islander researchers have been awarded a total of AU$7.4 million for projects dedicated to improving the health and

More targeted strategies, considering cultural safety, are required to improve outcomes for ethnic minority adults living with Type 2 Diabetes.